Clearmind Medicine Inc.CMNDNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank34
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P34
Within normal range
vs 5Y Ago
-2.5x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -20.57% |
| Q3 2025 | 1.50% |
| Q2 2025 | 18.63% |
| Q1 2025 | -24.38% |
| Q4 2024 | 4.14% |
| Q3 2024 | 4.04% |
| Q2 2024 | 17.06% |
| Q1 2024 | -160.92% |
| Q4 2023 | 45.25% |
| Q3 2023 | -28.65% |
| Q2 2023 | 65.54% |
| Q1 2023 | -12672.06% |
| Q4 2022 | 87.75% |
| Q3 2022 | 82.22% |
| Q2 2022 | 20.31% |
| Q1 2022 | 12.83% |
| Q4 2021 | -386.59% |
| Q3 2021 | 29.02% |
| Q2 2021 | -540.87% |
| Q1 2021 | -24.49% |
| Q4 2020 | 8.27% |
| Q3 2020 | 25.16% |
| Q2 2020 | -11124.10% |
| Q1 2020 | 108.21% |
| Q4 2019 | 58.59% |
| Q3 2019 | -683.64% |
| Q2 2019 | 85.89% |
| Q1 2019 | 75.14% |
| Q4 2018 | -38.84% |
| Q3 2018 | -345.58% |
| Q2 2018 | 47.15% |
| Q1 2018 | -17.50% |
| Q4 2017 | 0.00% |